share_log

Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200

Baird Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $200

貝爾德維持Inspire Medical Systems股票爲跑贏市場,但將目標價下調至200美元。
Benzinga ·  08/07 11:40  · 評級/大行評級

Baird analyst Mike Polark maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $220 to $200.

Baird分析師Mike Polark將Inspire Medical Systems(紐交所:INSP)評級爲增持,並將價格目標從220美元降至200美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論